Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mihaela Achille"'
Autor:
Suzette Delaloge, Anne-Claire Hardy-Bessard, Thomas Bachelot, Jean-Yves Pierga, Jean-Luc Canon, Florian Clatot, Fabrice André, Thibault De La Motte Rouge, Barbara Pistilli, Florence Dalenc, Nadine Dohollou, Olivier Arsene, Thierry Petit, Cecilia Riedl, François Morvan, Adina Marti, Emma Lachaier, Mihaela Achille, Michel Gozy, Anne Escande, Dominique Mille, Fanny Trouboul, Sandrine Marques, Jerome Lemonnier, Frederique Berger, François-Clément Bidard
Publikováno v:
Cancer Research. 82:P1-18
Background: Aromatase inhibitors (AI) in combination with a CDK 4/6 inhibitor have been established as the standard first line treatment of non AI-resistant hormone receptor-positive (HR+) HER2- metastatic breast cancer (mBC) patients (pts). ESR1 mut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3ed1ceaeeb83fea0838f976eb36ee13
https://doi.org/10.1158/1538-7445.sabcs21-p1-18-16
https://doi.org/10.1158/1538-7445.sabcs21-p1-18-16
Autor:
François-Clément Bidard, Anne-Claire Hardy-Bessard, Thomas Bachelot, Jean-Yves Pierga, Jean-Luc Canon, Florian Clatot, Fabrice Andre, Thibault De La Motte Rouge, Barbara Pistilli, Florence Dalenc, Nadine Dohollou, Olivier Arsene, Thierry Petit, Cécilia Riedl, François Morvan, Adina Marti, Emma Lachaier, Mihaela Achille, Michel Gozy, Anne Escande, Dominique Mille, Fanny Trouboul, Laurent Arnould, Ivan Bieche, Anne Pradines, Jerome Lemonnier, Frederique Berger, Suzette Delaloge
Publikováno v:
Cancer Research. 82:GS3-05
Background: ESR1 mutations are known drivers of resistance to first line aromatase inhibitors (AI)-based therapy in hormone receptor-positive (HR+) HER2- metastatic breast cancer (mBC) patients (pts), but their clinical actionability remains unknown.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad6dae5a1f11863098c2ac3cfc24208a
https://doi.org/10.1158/1538-7445.sabcs21-gs3-05
https://doi.org/10.1158/1538-7445.sabcs21-gs3-05
Autor:
Florent de Vathaire, Mihaela Achille, Jean-Charles Soria, Martin Schlumberger, Houda Boukheris, Laure Sabatier, Chantal Desmaze, Bernard Caillou, Monique Talbot
Publikováno v:
American Journal of Clinical Oncology. 32:1-8
Radiation exposure during childhood is the only well-established risk factor for papillary thyroid carcinoma (PTC). To better define the biologic profile of radiation-induced and sporadic PTC, we compared in these two groups of PTC the expression of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b5e44894616eb0687fa8bef27e53071
https://doi.org/10.1097/coc.0b013e3181783336
https://doi.org/10.1097/coc.0b013e3181783336